Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 9:08 pm Sale | 2026-06-30 | 13G | GALERA THERAPEUTICS INC GRTX | Ikarian Capital, LLC | 0 0.000% | -37,693 (Position Closed) | Filing History |
| 2026-06-11 5:30 pm Purchase | 2026-05-15 | 13D | GALERA THERAPEUTICS INC GRTX | Parvinder Singh Hyare | 67,610 6.650% | 67,610 (New Position) | Filing History |
| 2026-05-29 4:58 pm Purchase | 2026-05-15 | 13D | GALERA THERAPEUTICS INC GRTX | Emerald Bioventures, LLC | 305,150 30.200% | 104,069 (+51.75%) | Filing History |
| 2026-04-27 4:14 pm Purchase | 2026-04-07 | 13D | GALERA THERAPEUTICS INC GRTX | Emerald Bioventures, LLC | 201,081 26.500% | 201,081 (New Position) | Filing History |
| 2026-04-10 12:29 pm Purchase | 2024-12-30 | 13D | GALERA THERAPEUTICS INC GRTX | CHANG NANCY T | 44,608 5.900% | 44,608 (New Position) | Filing History |
| 2025-02-14 1:22 pm Purchase | 2024-12-31 | 13G | GALERA THERAPEUTICS INC GRTX | Ikarian Capital, LLC | 37,693 9.990% | 37,693 (New Position) | Filing History |
| 2024-05-16 10:26 am Unchanged | 2024-04-16 | 13G | GALERA THERAPEUTICS INC GRTX | Schneid Yair | 54,118 19.900% | 0 (Unchanged) | Filing History |
| 2024-05-16 10:25 am Purchase | 2024-04-16 | 13G | GALERA THERAPEUTICS INC GRTX | Soffer Rochel | 29,641 10.899% | 29,641 (New Position) | Filing History |
| 2024-05-01 5:01 pm Purchase | 2024-04-19 | 13G | GALERA THERAPEUTICS INC GRTX | Schneid Yair | 54,118 19.900% | 18,564 (+52.21%) | Filing History |
| 2024-04-16 4:39 pm Purchase | 2024-03-22 | 13G | GALERA THERAPEUTICS INC GRTX | ALPHA PHARMA Investments LLC | 13,750 5.056% | 13,750 (New Position) | Filing History |
| 2024-04-03 08:08 am Sale | 2024-04-01 | 13G | GALERA THERAPEUTICS INC GRTX | Altamont Pharmaceutical Holdings LLC | 0 0.000% | -26,400 (Position Closed) | Filing History |
| 2024-02-20 6:57 pm Sale | 2023-02-16 | 13D | GALERA THERAPEUTICS INC NE GRTXD | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 0 0.000% | -3,083,712 (Position Closed) | Filing History |
| 2024-02-14 10:14 am Sale | 2023-12-31 | 13G | EFFECTOR THERAPEUTICS INC EFTR | SECTORAL ASSET MANAGEMENT INC | 0 0.000% | -2,382,644 (Position Closed) | Filing History |
| 2024-01-16 6:09 pm Purchase | 2024-01-05 | 13G | GALERA THERAPEUTICS INC GRTX | Schneid Yair | 35,554 13.073% | 35,554 (New Position) | Filing History |
| 2024-01-02 08:35 am Purchase | 2024-01-02 | 13G | GALERA THERAPEUTICS INC GRTX | GSA CAPITAL PARTNERS LLP | 19,463 7.156% | 19,463 (New Position) | Filing History |
| 2023-12-04 4:32 pm Purchase | 2023-12-04 | 13D | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings I/II GP L.L.C. | 11,448 4.200% | 75 (+0.66%) | Filing History |
| 2023-11-13 2:24 pm Purchase | 2023-10-31 | 13G | GALERA THERAPEUTICS INC GRTX | Altamont Pharmaceutical Holdings LLC | 26,400 12.020% | 26,400 (New Position) | Filing History |
| 2023-06-28 4:19 pm Sale | 2023-06-27 | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 10,500 4.900% | -1,795 (-14.60%) | Filing History |
| 2023-02-27 5:43 pm Purchase | 2023-02-17 | 13G | GALERA THERAPEUTICS INC GRTX | Deerfield Mgmt, L.P. | 14,582 4.990% | 14,582 (New Position) | Filing History |
| 2023-02-13 3:03 pm Sale | 2022-12-31 | 13G | EFFECTOR THERAPEUTICS INC EFTR | SECTORAL ASSET MANAGEMENT INC | 66,667 5.800% | -28,643 (-30.05%) | Filing History |